Cycloserine contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cycloserine}} | {{Cycloserine}} | ||
{{CMG}} ; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
==Contraindications | |||
Administration is contraindicated in patients with any of the following: | Administration is contraindicated in patients with any of the following: | ||
Hypersensitivity to cycloserine | * Hypersensitivity to cycloserine | ||
* [[Epilepsy]] | |||
[[Epilepsy]] | * [[Depression]], severe [[anxiety]], or [[psychosis]] | ||
* Severe [[renal insufficiency]] | |||
Depression, severe anxiety, or psychosis | * Excessive concurrent use of alcohol<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e08327-4b90-463e-bb2a-22438cabcef2 | publisher = | date = | accessdate }}</ref> | ||
Severe renal insufficiency | |||
Excessive concurrent use of alcohol<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e08327-4b90-463e-bb2a-22438cabcef2 | publisher = | date = | accessdate }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 02:38, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Administration is contraindicated in patients with any of the following:
- Hypersensitivity to cycloserine
- Epilepsy
- Depression, severe anxiety, or psychosis
- Severe renal insufficiency
- Excessive concurrent use of alcohol[1]
References
- ↑ "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.